Howard Univ Hosp

Washington D.C., District of Columbia 20060

0 studies enrolling now · 28 studies all time

What they study most

Bacterial Infections, HIV Infections, HIV Seronegativity, Hepatitis C, Papilloma, Pneumonia, Pneumocystis Carinii, Pregnancy

Studies at this site

• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children — Completed
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens — Completed
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs — Completed
• A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3 — Completed
• A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children — Completed
• Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children — Completed
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV — Completed
• A Study to Compare Two Different Anti-HIV Drug Regimens — Completed
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants — Completed
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment — Completed
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children — Completed
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns — Completed
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants — Completed
• A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children. — Completed
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection — Completed
• The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women — Completed
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants — Completed
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV — Completed
• Prevalence of Hepatitis C Virus Infection in HIV-Infected Children — Completed
• A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications — Completed
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children — Completed
• Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems — Completed
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) — Completed
• A Blood Test to Look at Cells of the Immune System in Healthy Children — Completed
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women — Completed
• Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine — Completed